These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 25671187)
1. Inhibition of Angiogenesis and Nitric Oxide Synthase (NOS), by Embelin & Vilangin Using in vitro, in vivo & in Silico Studies. Narayanaswamy R; Shymatak M; Chatterjee S; Wai LK; Arumugam G Adv Pharm Bull; 2014 Dec; 4(Suppl 2):543-8. PubMed ID: 25671187 [TBL] [Abstract][Full Text] [Related]
2. Thalidomide attenuates nitric oxide mediated angiogenesis by blocking migration of endothelial cells. Tamilarasan KP; Kolluru GK; Rajaram M; Indhumathy M; Saranya R; Chatterjee S BMC Cell Biol; 2006 Apr; 7():17. PubMed ID: 16584574 [TBL] [Abstract][Full Text] [Related]
3. Hypoglycemic activity of 6-bromoembelin and vilangin in high-fat diet fed-streptozotocin-induced type 2 diabetic rats and molecular docking studies. Stalin A; Irudayaraj SS; Gandhi GR; Balakrishna K; Ignacimuthu S; Al-Dhabi NA Life Sci; 2016 May; 153():100-17. PubMed ID: 27091376 [TBL] [Abstract][Full Text] [Related]
4. Bioinformatics in crosslinking chemistry of collagen with selective cross linkers. Swamy RN; Gnanamani A; Shanmugasamy S; Gopal RK; Mandal AB BMC Res Notes; 2011 Oct; 4():399. PubMed ID: 21989371 [TBL] [Abstract][Full Text] [Related]
5. Embelin, a Potent Molecule for Alzheimer's Disease: A Proof of Concept From Blood-Brain Barrier Permeability, Acetylcholinesterase Inhibition and Molecular Docking Studies. Bhuvanendran S; Hanapi NA; Ahemad N; Othman I; Yusof SR; Shaikh MF Front Neurosci; 2019; 13():495. PubMed ID: 31156375 [TBL] [Abstract][Full Text] [Related]
6. Cadmium attenuates bradykinin-driven nitric oxide production by interplaying with the localization pattern of endothelial nitric oxide synthase. Majumder S; Gupta R; Reddy H; Sinha S; Muley A; Kolluru GK; Chatterjee S Biochem Cell Biol; 2009 Aug; 87(4):605-20. PubMed ID: 19767824 [TBL] [Abstract][Full Text] [Related]
7. Potent inhibition of human 5-lipoxygenase and microsomal prostaglandin E₂ synthase-1 by the anti-carcinogenic and anti-inflammatory agent embelin. Schaible AM; Traber H; Temml V; Noha SM; Filosa R; Peduto A; Weinigel C; Barz D; Schuster D; Werz O Biochem Pharmacol; 2013 Aug; 86(4):476-86. PubMed ID: 23623753 [TBL] [Abstract][Full Text] [Related]